Clinical Trials and Research

Login or register to access the content restricted to healthcare professionals only

ADVANCED CLINICAL
TRIAL PIPELINE

Clinical Trial	Extract	Background	Current status	Comment
Phase I PK Study	Bod ECS315	Pharmacokinetics safety and tolerability of CBD extract	INITIATED IN PROGRESS COMPLETED	Differentiated by our R&D. This work optimised the design of our schedule 3 clinical trial
Toxicology	Bod ECS315	Safety evaluation of ECS315 For Novel Food registration	INITIATED IN PROGRESS COMPLETED	We are 1 of only 6company globally to have secured a validated Novel Food Application. This is mandatory for CBD to sold in the UK and EU
BODOLOS Observational Study	Bod ECS315 & Bod ECS100	Real world evidence on doctors CBD prescribing habits	INITIATED IN PROGRESS COMPLETED	Provided important insight into dosing decisions and design of our schedules 3 clinical trial
CBG Pilot Study	Bod ECS317	Evaluation of the efficiency of a novel CBG compound	INITIATED IN PROGRESS COMPLETED	Investigate the effect of CBG on symptoms associated with fibromyalgia, inflammatory bowel disease and anxiety
Project Chang’e	Bod ECS317 & Bod ECS100	Evaluating the combination of different cannabinoids and probiotics targeting stress, anxiety and inflammation in animals	INITIATED IN PROGRESS	Data will support future product launches using combination of CBG and CBD
Phase1 PK study	BOD Bio Absorb	Pharmacokinetics, safety and tolerability of novel CBD compound	INITIATED IN PROGRESS COMPLETED	Data will support FDA registration and others commercial opportunities
Phase II Insomnia Study	Bod Bio Absorb	Using a novel CBD to treat insomnia	INITIATED IN PROGRESS	clinical trial will allow Bod to secure a registration from TGA. this will allow the product to be sold in Australian Pharmacy’s over the counter.
Long-COVID Study	Bod ECS315	Evaluating the efficacy of CBD for symptoms associated with long-COVID	INITIATED IN PROGRESS	This study provide a unique opportunity to alleviate multiple symptoms of long covid using one medicine
Emerald Study Phase II study	Bod ECS315	The use of CBD in slowing progression of Motor Neuron Disease	INITIATED IN PROGRESS	Collaboration with Gold Coast University Hospital
Phase I CBN Insomnia Study	Bod Es310	Using CBN treating primary insomnia	INITIATED IN PROGRESS	Collaboration with Sydney University & The Woolcock Institute
Project Skin	Novel Protein	Evaluating the efficacy of a novel protein for inhibiting free radical damage on skin	INITIATED IN PROGRESS	At completion, Bod will own unique and novel delivery format of an anti-aging agent for topical use